UniProt: P62593 Gene symbol: bla (TEM) Protein: β-lactamase TEM Organism: Escherichia coli (taxonomy ID 562) Disease (MONDO): not applicable — this is a pathogen drug-resistance enzyme, not a host disease gene. Adjacent ontology: NCBIT taxon 562; DOID:0050486 (drug-resistant infection). Disease class: infectious-disease drug-resistance target (not a Mendelian disease); class A serine β-lactamase.
A medicinal-chemistry team scopes a β-lactamase inhibitor program. They need: the catalytic machinery (Ser-70 nucleophile + the oxyanion hole + the general base), the Sec-system signal peptide and mature-chain boundaries, and the structural evidence (many-PDB-structures-of-the-canonical-enzyme story).
| # | Tool | Question |
|---|---|---|
| 1 | uniprot_search("protein_name:\"Beta-lactamase TEM\" AND organism_id:562 AND reviewed:true", size=1) |
Confirm canonical accession (P62593). |
| 2 | uniprot_get_entry("P62593") |
Function (β-lactam hydrolysis), 286 aa, periplasmic localisation. |
| 3 | uniprot_get_active_sites("P62593") |
The headline tool: Ser-70 (nucleophile), Glu-166 (general base), Lys-234 (oxyanion stabilisation), Ser-130 (substrate binding). |
| 4 | uniprot_get_processing_features("P62593") |
23-aa Sec signal peptide; mature chain residues 24–286. |
| 5 | uniprot_get_ptms("P62593") |
Empty advisory — bacterial Sec-secreted enzymes typically have no curated PTMs (the empty advisory points at PhosphoSitePlus / GlyConnect for completeness). |
| 6 | uniprot_resolve_pdb("P62593") |
Many high-resolution structures; canonical 1BTL at 1.80 Å, 1JTG at 1.73 Å, etc. |
| 7 | uniprot_resolve_chembl("P62593") |
β-lactamase inhibitors (clavulanate, sulbactam, tazobactam) and avibactam-class diazabicyclooctanes. |
- Step 3: at least four Active site / Binding site annotations clustered in the active-site cleft (Ser-70, Glu-166, Lys-234, Ser-130).
- Step 4:
Signal peptide1–23 +Chain24–286. - Step 5:
0 feature(s)with the honest empty advisory pointing at PhosphoSitePlus / GlyConnect — bacterial periplasmic enzymes are typically PTM-free. - Step 6: 30+ PDB structures; the best at 1.73 Å (1JTG).
- β-lactamase inhibitors — small molecules that occupy the active site and prevent β-lactam hydrolysis. Three "classical" inhibitors (clavulanate, sulbactam, tazobactam) form a covalent acyl-enzyme intermediate at Ser-70 that is more stable than the productive hydrolytic intermediate.
- Newer-generation inhibitors: diazabicyclooctanes (avibactam, relebactam, durlobactam) — reversible covalent binders; boronate-based (vaborbactam, taniborbactam) — transition-state mimics.
- Class shift: TEM-1 is a class A serine β-lactamase. Carbapenemases (KPC, NDM, OXA, IMP) and metallo-β-lactamases (NDM-1) require different inhibitor chemistries — but the active-site geometry tool surfaces those mechanism differences.
- ChEMBL bridge: β-lactamase is a richly-populated target with small-molecule, peptide, and natural-product inhibitors.
Standard envelope on every response.
| Resource | Returned via |
|---|---|
| PDB | Many high-resolution apo and inhibitor-bound structures. |
| AlphaFold DB | AF-P62593-F1 (very high confidence over the entire fold). |
| ChEMBL | Rich; clavulanate, sulbactam, tazobactam, avibactam, vaborbactam, relebactam, more. |
| InterPro | Class A β-lactamase signature (PF00144 etc.). |
| Ontology | Identifier |
|---|---|
| NCBI taxonomy | 562 (E. coli) |
| ARO (CARD) | ARO:3000014 (TEM-1) — the Antibiotic Resistance Ontology canonical entry |
| DOID | DOID:0050486 (drug-resistant infection) |
TEM-1 is the canonical infectious-disease drug-target case. It
demonstrates that the same uniprot_get_active_sites /
uniprot_get_processing_features / uniprot_get_ptms workflow
that handles human enzymes (PAH) also handles pathogen enzymes —
the tool surface is organism-agnostic. The empty PTM advisory is
honest and informative for a bacterial periplasmic enzyme.